Biotechnology company Nuclera has introduced an antibody screening service to enable quick access to high-quality proteins and advance AI-driven discovery. “Antibodies are one of the most important ...
Sino Biological, the regional subsidiary of global life science reagent and service provider Sino Biological, has recently ...
In April 2025, the US Food and Drug Administration (FDA) announced plans to phase out certain animal testing requirements, ...
The collaboration aims to discover novel therapies for liver disease, including metabolic dysfunction-associated ...
Through this agreement, Cellular Intelligence will advance the continued clinical development of the cell therapy Parkinson’s program and provide disease-modifying therapy for p ...
By using this site, you agree to the Privacy Policy and Terms of Use. Accept ...
Globally, RSV is responsible for an immense health and economic burden, causing an estimated 33 million new ALRI cases and over three million hospitalisations each year in children under the age of ...
Quotient Sciences, an integrated Contract Research, Development and Manufacturing Organisation, has extended its commercial supply partnership with Ipsen, a global biopharmaceutical company, to ...
Lundbeck will be presenting its research at the 2026 Alzheimer’s and Parkinson’s Disease conference Lundbeck has shared that new data from a Phase 1b proof-of-mechanism trial of Lu AF28996, a novel ...
Leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and research, Axol Bioscience, today announced that it has acquired the ophthalmology business of Newcells ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results